Generic filters
Search in excerpt

Un FNB pour chaque investisseur.

The World’s First Psychedelics ETF

Prix
$0.00
$0.00
0.00%
Valeur liquidative
$--
$--
--%

Titre Thématique

Aperçu du FNB
En savoir plus sur

QQCC

FNB Horizons Options d’achat couvertes NASDAQ-100

Prix
$11.45
$0.04
0.35%
Valeur liquidative
$11.4793
$0.0794
0.70%

Active

Options D'achat Couvertes

Aperçu du FNB
En savoir plus sur QQCC

HSAV

FNB Horizons Compte maximiseur d’espèces

Prix
$111.30
$-0.12
-0.11%
Valeur liquidative
$110.7731
$0.0145
0.01%

Catégorie de Société - Rendement Total

Indices

Aperçu du FNB
En savoir plus sur HSAV
Explorer tous les produits
Generic filters
Search in excerpt

This Webinar Covers:

On January 27, 2021, Horizons ETFs launched the Horizons Psychedelic Stock Index ETF (PSYK), which offers investors unique exposure to the emerging North American psychedelics industry.

On February 18, 2021, we hosted a webinar that saw more than 1,000 investors join us to learn about the potential of the psychedelics sector and our investing insights.

You can now watch our webinar replay with Steve Hawkins, CEO of Horizons ETFs, and Mark Noble, Executive Vice-President of ETF Strategy, uncover the potential investment opportunities presented by psychedelic therapeutics and research being pursued by Canadian and American life sciences companies, including some of the world’s largest pharmaceutical names.